Professional Summary

Professional Overview

Amy Rabourn is an accomplished finance executive with over 15 years of experience in the pharmaceutical and technology industries. As the Senior Vice President of Finance at Ocuphire Pharma, she oversees all financial operations, strategy, and reporting for the rapidly growing biopharmaceutical company.

Experience Summary

Current Role

As the SVP of Finance at Ocuphire Pharma since January 2023, Amy is responsible for leading the company's financial management, including budgeting, forecasting, treasury, and regulatory compliance. She has played a crucial role in securing multiple financing rounds, enabling Ocuphire Pharma to advance its pipeline of novel ophthalmic therapies. Amy's strategic financial leadership has been instrumental in positioning the company for long-term growth and success.

Career Progression

Prior to her current role, Amy served as the Vice President of Finance at Ocuphire Pharma, where she was instrumental in the company's successful IPO and subsequent public financing activities. She has also held finance leadership positions at NeuroBo Pharmaceuticals, Gemphire Therapeutics, and MyBuys, Inc., where she consistently demonstrated her ability to drive operational efficiency and financial optimization.

Amy began her career as an Assurance Advisor at PricewaterhouseCoopers, providing audit and advisory services to clients in various industries. Her diverse experience has equipped her with a deep understanding of financial reporting, regulatory compliance, and strategic planning.

Academic Background

Amy holds a Bachelor of Business Administration degree in Accounting from the University of Michigan, where she graduated with honors.

Areas of Expertise

• Financial planning, budgeting, and forecasting

• Treasury management and cash flow optimization

• SEC reporting and regulatory compliance

• Mergers, acquisitions, and integration

• Investor relations and capital markets

Professional Impact

Throughout her career, Amy has played a pivotal role in securing critical financing for her employers, enabling them to achieve their strategic objectives. Her expertise in financial reporting and regulatory compliance has been instrumental in maintaining the trust of investors, auditors, and regulatory authorities.

Conclusion

With her extensive experience in the pharmaceutical and technology sectors, Amy Rabourn is a highly respected finance executive who consistently delivers value to her organizations. Her strategic leadership, technical expertise, and commitment to excellence make her a valuable asset to Ocuphire Pharma as the company continues to grow and advance its innovative ophthalmic therapies.